|
SEC62 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.44729999785565E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.81121784237348E-12 |
| Stage1-vs-Stage2 |
2.797200E-01 |
| Stage1-vs-Stage3 |
1.827500E-04 |
| Stage1-vs-Stage4 |
9.310000E-02 |
| Stage2-vs-Stage3 |
2.817000E-03 |
| Stage2-vs-Stage4 |
5.393900E-02 |
| Stage3-vs-Stage4 |
5.459000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.48959999890508E-09 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
5.990800E-01 |
| Caucasian-vs-Asian |
7.754800E-01 |
| AfricanAmerican-vs-Asian |
5.420000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
7.882200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62581059726108E-12 |
| Normal-vs-Age(81-100Yrs) |
8.96890000046113E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.745400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.942400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.082000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.302800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.576600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.852200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.11349999910271E-08 |
| Classical-VS-Follicular |
1.86989999995113E-06 |
| Classical-VS-Other |
3.947200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.83419945898322E-12 |
| Tall-VS-Other |
1.670960E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.807400E-04 |
| Follicular-VS-Normal |
2.37069999999839E-05 |
| Other-VS-Normal |
3.64739999980657E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
2.37254660362396E-13 |
| N0-vs-N1 |
8.202200E-02 |
|
|
